Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Stefano Molica, MD, Giovanna Digiesi, MD, Anna Antenucci, MD, Luciano Levato, Rosanna Mirabelli, MD, Massimo Gentile, MD, Diana Giannarelli, MD, Isabella Sperduti, PhD, Fortunato Morabito, MD, Laura Conte, MD

Blood (2011) 118 (21): 4601.

https://doi.org/10.1182/blood.V118.21.4601.4601

Published: 2011

Journal Articles

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Stefano Molica, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Rosanna Mirabelli, MD, Giovanna Digiesi, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Fortunato Morabito, Manlio Ferrarini, MD

Blood (2008) 112 (11): 4187.

https://doi.org/10.1182/blood.V112.11.4187.4187

Published: 2008

Journal Articles

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD

Blood (2008) 112 (11): 4158.

https://doi.org/10.1182/blood.V112.11.4158.4158

Published: 2008

Journal Articles

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD

Blood (2007) 110 (11): 3093.

https://doi.org/10.1182/blood.V110.11.3093.3093

Published: 2007

Journal Articles

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Stefano Molica, MD, Gaetano Vitelli, MD, Giovanna Cutrona, MD, Giovanna Digiesi, MD, Rosanna Mirabelli, MD, Diana Giannarelli, MD, Isabella Sperduti, MD, Manlio Ferrarini, MD

Blood (2006) 108 (11): 2786.

https://doi.org/10.1182/blood.V108.11.2786.2786

Published: 2006

NARROW

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

VITAMIN D Insufficiency Affects Time to FIRST TREATMENT (TFT) In EARLY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Serum CD26 (Dipeptidyl Peptidase IV, DPP IV) compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Serum Adiponectin Compared with ZAP-70, CD38 and Immunoglobulin Heavy-Chain Mutation Status as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only